Ambria Capital

Healing Maps is a Miami-based mental health platform established in 2020, dedicated to providing education and information on psychedelic-assisted therapies, particularly focusing on ketamine treatment and other medical psychedelics. The company offers a comprehensive directory that helps individuals locate nearby clinics, alongside in-depth articles that deliver accurate and honest insights into the benefits and applications of psychedelic therapies for mental wellness. By empowering patients with the knowledge they need, Healing Maps aims to facilitate informed decisions regarding their mental health treatment options.

Tyson 2.0 is a cannabis company founded by renowned boxer and entrepreneur Mike Tyson, focused on producing high-quality cannabis products. The company offers a diverse range of offerings, including full-spectrum cannabis flower, concentrates, and consumables, which are designed to ensure both purity and precision. Tyson 2.0 aims to provide consumers with an exceptional selection that balances premium quality and affordability, making its products widely accessible at retailers across the nation.

Wonder Sciences is a company focused on advancing mental health and wellness through innovative approaches involving psychedelic therapies and somatic protocols. It operates three main divisions: Wondermed, which partners with physicians to provide holistic healing solutions; Wonder Clinics, which are mental health centers that integrate psychedelic-assisted therapies with traditional medicine and neuroscience; and Wonder Research, dedicated to conducting clinical studies aimed at developing evidence-based psychedelic protocols. The company's online telemedicine platform allows patients dealing with depression and anxiety to engage in therapeutic journeys from home, utilizing novel protocols and scientific research to facilitate self-healing and elevate overall well-being.

Semasio GmbH, founded in 2010 and headquartered in Hamburg, Germany, specializes in user intelligence and targeting solutions for digital advertising. The company leverages statistical modeling and machine learning to provide a platform that helps marketers build detailed user profiles and identify target groups. Semasio's offerings include Audience Targeting, Contextual Targeting, and Brand Fit Targeting, utilizing Natural Language Processing to analyze website content and create comprehensive profiles for both websites and users. This enables clients, including global agency networks and advertisers, to strategically address specific audiences and optimize their advertising efforts. Additionally, Semasio's technology allows for precise control over the contextual placements of online advertising content, ensuring relevance and efficiency. With development centers in Denmark and Portugal, Semasio is dedicated to enhancing the effectiveness of programmatic advertising in a privacy-conscious environment.

MycroDose Therapeutics is a U.S.-based pharmaceutical company focused on developing advanced drug delivery systems that utilize psychedelic compounds for the treatment of mental health disorders and cognitive degenerative diseases. The company is actively working on two of its four core technologies, which include a psilocybin transdermal delivery system and a ketamine oral mucosa delivery system. By leveraging these innovative approaches, MycroDose Therapeutics aims to enhance the efficacy and accessibility of treatments for patients dealing with these challenging conditions.

NanoPsy is a company that develops nanotechnology for theranostic applications to effectively improve psychedelic drug efficacy. Our patented nano technology which, in combination with our targeted delivery and controlled dosing technology methods, will allow for an increase in solubility/absorption of these molecules. Thus a more efficacious API.

WeSana Health is a life sciences company focused on the advancement of psilocybin-based medicine. Founded in 2020 by Daniel Carcillo, the company is headquartered in Homer Glen, Illinois. WeSana Health is actively exploring new business opportunities to further its mission in the burgeoning field of psychedelics, aiming to develop innovative therapeutic solutions for various mental health conditions.

WeSana Health is a life sciences company focused on the advancement of psilocybin-based medicine. Founded in 2020 by Daniel Carcillo, the company is headquartered in Homer Glen, Illinois. WeSana Health is actively exploring new business opportunities to further its mission in the burgeoning field of psychedelics, aiming to develop innovative therapeutic solutions for various mental health conditions.